You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
There are a number of choices when deciding what SCS system is right for you. Together with your doctor, select the SCS system that has the features that benefit you most.
480,000 approx.
people with chronic pain worldwide have been helped by Medtronic therapy.‡
†
Under specific conditions. Talk to your doctor and refer to product labeling for a full list of conditions.
‡ Data on file.
![]() |
![]() |
||
| Options to suit your needs |
Inceptiv™ rechargeable SCS | Vanta™ recharge-free SCS | |
| Personalized pain relief with closed-loop sensing technology | ✔ | n/a | |
| Therapy adjustments based on body position with AdaptivStim™ feature | ✔ | ✔ | |
| Full-body MRI scans† | ✔ | ✔ | |
| Small, comfortable device size | ✔ | ✔ | |
| Access to network of Medtronic support | ✔ | ✔ | |
| Industry-leading battery longevity | >95% battery capacity retained at 9 years*,2 |
Variable, based on programming | |
| Fast battery recharge | ✔ | n/a | |
| Recharge-free convenience | n/a | ✔ | |
| *Recharge-free devices are parameter dependent, and longevity can vary depending on settings. |
|||
Implanting the SCS system requires surgery which can have serious complications. Once the neurostimulation system is implanted, it’s possible that device complications may occur. Talk with your doctor to fully understand the risks and benefits of any therapy.
Call Medtronic Patient Services if you have questions about or problems with your neurostimulation device. As a medical device manufacturer, Medtronic can offer technical assistance. We are not able to comment on your medical condition.
+44 (0)1923 205101 Monday to Friday, 9am-4pm.
Click on the link below to view locations of centres offering Spinal Cord Stimulation in the UK and Ireland.
Medical Disclaimer
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional.
Fishman M, Cordner H, Justiz R, et al. Twelve-month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021;21(8):912–923.
Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63(4):762–770; discussion 770.
Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. Effect of spinal cord stimulation for chronic complex regional pain syndrome type 1: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg. 2008;108(2):292–298.
Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicenter randomized controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1-2):179–188.
North RB, Kidd D, Shipley J, Taylor RS. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery. 2007;61(2):361–369.
Gee L, Smith HC, Ghulam-Jelani Z, et al. Spinal Cord Stimulation for the Treatment of Chronic Pain Reduces Opioid Use and Results in Superior Clinical Outcomes When Used Without Opioids. Neurosurgery. 2018. A non-randomized prospective cohort study of SCS patients between September 2012 and August 2015 (N=86 [n=53 on opioids]).
Sharan AD, Riley J, Falowski S, et al. Association of Opioid Usage with Spinal Cord Stimulation Outcomes. Pain Med. December 2017. A non- randomized analysis of Truven Health Marketscan databases from January 2010 to December 2014 based on the First occurrence of an SCS implant (N= 5,476).
Pollard EM, Lamer TJ, Moeschler SM, et al. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. Journal of Pain Research. 2019:12 1311–1324. A research review summarizing SCS studies with respect to opioid use and a further meta-analysis of comparative SCS RCTs of 1 year or greater duration (N=489).